loadpatents
Patent applications and USPTO patent grants for Taggart; John J..The latest application filed is for "2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy".
Patent | Date |
---|---|
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy Grant 8,058,282 - Adams , et al. November 15, 2 | 2011-11-15 |
2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one Compounds And Compositions For Use In Therapy App 20110046109 - Adams; Jerry L. ;   et al. | 2011-02-24 |
Novel Compounds App 20110009625 - Adams; Jerry L. ;   et al. | 2011-01-13 |
2,4,5-Trisubstituted pyrimidine compounds Grant 7,759,486 - Adams , et al. July 20, 2 | 2010-07-20 |
Compounds Grant 7,700,768 - Adams , et al. April 20, 2 | 2010-04-20 |
Tetrasubstituted pyrimidine compounds as chemical intermediates Grant 7,629,462 - Adams , et al. December 8, 2 | 2009-12-08 |
Muscarinic Acetylcholine Receptor Antagonists App 20090258858 - Busch-Petersen; Jakob ;   et al. | 2009-10-15 |
Novel Compounds App 20090137550 - Boehm; Jeffrey C. ;   et al. | 2009-05-28 |
Novel Compounds App 20090105478 - ADAMS; JERRY L. ;   et al. | 2009-04-23 |
Novel compounds App 20090048442 - Adams; Jerry L. ;   et al. | 2009-02-19 |
Novel Compounds App 20090005401 - Boehm; Jeffrey C. ;   et al. | 2009-01-01 |
Novel Process and Formulations App 20080268044 - Appleby; John Robert George ;   et al. | 2008-10-30 |
Chemical Compounds App 20080269291 - Kerns; Jeffrey K. ;   et al. | 2008-10-30 |
Compounds Grant 7,423,042 - Boehm , et al. September 9, 2 | 2008-09-09 |
Novel Compounds App 20080032969 - Adams; Jerry L. ;   et al. | 2008-02-07 |
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds Grant 7,323,472 - Adams , et al. January 29, 2 | 2008-01-29 |
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds Grant 7,314,881 - Adams , et al. January 1, 2 | 2008-01-01 |
4-amino substituted-6-aryl/heteroaryl substituted-2-methylsulfanyl-pyrimidine-5-carbaldehyde intermediates Grant 7,314,934 - Adams , et al. January 1, 2 | 2008-01-01 |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one Compounds And Their Use In Treating Csbp/p38 Kinase Mediated Diseases App 20070238743 - Adams; Jerry L. ;   et al. | 2007-10-11 |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one Compounds And Their Use In Treating Csbp/p38 Kinase Mediated Diseases App 20070167467 - Adams; Jerry L. ;   et al. | 2007-07-19 |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases Grant 7,235,551 - Adams , et al. June 26, 2 | 2007-06-26 |
Novel compounds App 20060217401 - Boehm; Jeffrey C. ;   et al. | 2006-09-28 |
Novel Compounds App 20050203109 - Adams, Jerry L. ;   et al. | 2005-09-15 |
Novel compounds App 20040209901 - Adams, Jerry L. ;   et al. | 2004-10-21 |
Novel compounds App 20040116697 - Adams, Jerry L. ;   et al. | 2004-06-17 |
1,5- disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases App 20030100756 - Adams, Jerry L ;   et al. | 2003-05-29 |
Water soluble camptothecin analogs Grant 5,663,177 - Berges , et al. September 2, 1 | 1997-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.